NCT06318507View on ClinicalTrials.gov

The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

RecruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast Neoplasms
Interventions
COMBINATION_PRODUCT

Fecal microbial diversity

Fecal microbiome diversity via 16S rRNA and metagenomic sequencing

Trial Locations (1)

70808

RECRUITING

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER